The UK is the world's largest producer and exporter of medical cannabis according to the UN, while banning its recreational use.
The United Kingdom produced 95 tons of medical and legal cannabis in 2016. This is more than double the total of the previous year, reveals the UN International Narcotics Control Board. This represented 44,9% of the world total. The closest competitor is Canada with 80,7 tons.
The United Kingdom exports about 2,1 tonnes, which makes it responsible for 67,7% of the world total, followed by the Netherlands (16,4%).
A drug policy reform lobby group, Transform, has criticized the UK government. Thus this group asserts that the authorities have "systematically refused to allow medical cannabis in the UK because it had "no therapeutic value".
State hypocrisy over medical cannabis
Steve Rolles, senior policy analyst at Transform, said: “It is scandalous and indefensible for the UK government to argue that cannabis has no medical use, while licensing the world's largest production and export market. of medical cannabis.
“British patients are being denied access and unnecessary suffering. They are forced to buy cannabis on the criminal market. "-" Countries with adequate access to medical cannabis do not have this problem, as standardized cannabis products are in the hands of doctors and pharmacists. "
A British company behind Sativex
A significant portion of legal cannabis production in the UK goes towards a drug. This is a cannabis-based treatment called Sativex. This drug is produced by GW Pharmaceuticals. Indeed, this pharmaceutical company founded in 1998 is based on medical cannabis.
It is only available by prescription for patients of certain diseases. So those who are suffering from the effects of multiple sclerosis. However, it is booked only on the NHS (National Health Service) in Wales.